MGNX

AS OF

Nov 19, 04:59 PM (EDT)

Price

$1.42

Change

-$0.12 (-7.79%)

Capitalization

97.73M

92 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

MGNX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

MacroGenics (MGNX) Earnings Date & Reports

Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

MGNX is expected to report earnings to fall 199.85% to -26 cents per share on February 19

Q4'25

Est.

$-0.27

Q3'25

Beat

by $0.68

Q2'25

Missed

by $0.11

Q1'25

Est.

$-0.65

Q4'24

Beat

by $0.16

The last earnings report on November 12 showed earnings per share of 27 cents, beating the estimate of -40 cents. With 528.98K shares outstanding, the current market capitalization sits at 97.73M.

View a ticker or compare two or three

Compare

MGNX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MGNX showed earnings on November 12, 2025. You can read more about the earnings report here.

View AI-Driven Trading for MGNX

A.I. Advisor

published General Information

General Information

a company, which engages in the discovery and development of monoclonal antibody-based therapeutics

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

9704 Medical Center Drive

Phone

+1 301 251-5172

Employees

339

Web

https://www.macrogenics.com